CTC-specific expression profile associates with the PI3K/AKT, ERK1/2 and NF-kB pathways. NOTCH1, PTP4A3, LGALS3 and ITGB3 were further validated by RT-qPCR in an independent cohort of NSCLC patients. Here, MAPK3 is linked to non-small cell lung carcinoma.